We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+19.64%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$201M
AUM Growth
+$9.03M
Cap. Flow
-$6.66M
Cap. Flow %
-3.32%
Top 10 Hldgs %
89.23%
Holding
43
New
1
Increased
1
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
ALT icon
Altimmune
ALT
+$1.01M
2
ASML icon
ASML
ASML
+$1.01M

Top Sells

Rank Stock Value
1
DOW icon
Dow Inc
DOW
+$1.9M
2
LUMN icon
Lumen
LUMN
+$1.5M
3
ANVS icon
Annovis Bio
ANVS
+$1.44M
4
CTVA icon
Corteva
CTVA
+$1.33M
5
DD icon
DuPont de Nemours
DD
+$1.16M

Sector Composition

Rank Sector Weight
1 Healthcare 86.53%
2 Technology 2.68%
3 Materials 2.07%
4 Financials 1.93%
5 Communication Services 0.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$119M 59.36%
856,844
– –
APLT
2
DELISTED
Applied Therapeutics
APLT
$17.1M 8.54%
1,032,123
– –
ENTX icon
3
Entera Bio
ENTX
$101M
$11.7M 5.84%
2,484,275
– –
CRBP icon
4
Corbus Pharmaceuticals
CRBP
$170M
$5.15M 2.57%
168,196
– –
ALDX icon
5
Aldeyra Therapeutics
ALDX
$91.7M
$5M 2.49%
569,405
– –
EIGR
6
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$4.64M 2.31%
23,141
– –
ABEO icon
7
Abeona Therapeutics
ABEO
$345M
$3.2M 1.6%
114,391
– –
BX icon
8
Blackstone
BX
$104B
$2.79M 1.39%
24,000
-6,000
-20% -$696K
ALT icon
9
Altimmune
ALT
$539M
$1.5M 0.75%
132,978
+82,978
+166% +$1.01M
AMD icon
10
Advanced Micro Devices
AMD
$851B
$1.27M 0.63%
12,350
– –
LUMN icon
11
Lumen
LUMN
$6.53B
$1.24M 0.62%
100,000
-120,000
-55% -$1.5M
CVS icon
12
CVS Health
CVS
$137B
$1.23M 0.61%
14,500
– –
TMO icon
13
Thermo Fisher Scientific
TMO
$211B
$1.2M 0.6%
2,100
– –
ANET icon
14
Arista Networks
ANET
$219B
$1.19M 0.59%
55,200
– –
V icon
15
Visa
V
$677B
$1.08M 0.54%
4,850
– –
MO icon
16
Altria Group
MO
$122B
$1.03M 0.52%
22,700
– –
VMW
17
DELISTED
VMware, Inc
VMW
$1.03M 0.52%
6,950
– –
BAH icon
18
Booz Allen Hamilton
BAH
$8.7B
$1.03M 0.51%
13,000
– –
GLW icon
19
Corning
GLW
$126B
$971K 0.48%
26,600
– –
XCUR icon
20
Exicure
XCUR
$11.2M
$962K 0.48%
5,346
-3,173
-37% -$643K
ASML icon
21
ASML
ASML
$675B
$912K 0.45%
+1,280
New +$1.01M
SNGX icon
22
Soligenix
SNGX
$5.5M
$835K 0.42%
3,286
– –
BTAI icon
23
BioXcel Therapeutics
BTAI
$26.2M
$607K 0.3%
1,250
– –
ELTX icon
24
Elicio Therapeutics
ELTX
$78.8M
$586K 0.29%
6,000
– –
MMX
25
DELISTED
Maverix Metals Inc. Common Shares
MMX
$514K 0.26%
115,000
– –
1
2

Similar funds

MGWA
Monument Group Wealth Advisors Concord, Massachusetts $180M AUM 19.81% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Knoll Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Knoll Capital Management held 43 positions worth $201M, up 4.7% from $191M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Knoll Capital Management withdrew a net $6.66M in Q3 2021, closing 3 positions and reducing 4 holdings. Its most notable exit was Dow Inc, an estimated $1.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 82% a quarter earlier, followed by Technology and Materials.

Against the trend, Knoll Capital Management opened a new position in ASML worth $912K.

  • Knoll Capital Management's largest Q3 2021 buy was ASML: 1,280 shares worth $912K.
  • Knoll Capital Management added most to Altimmune in Q3 2021, an estimated $1.01M increase.
  • Knoll Capital Management's biggest Q3 2021 reduction was Lumen, cutting an estimated $1.5M.
  • Knoll Capital Management fully exited Dow Inc in Q3 2021, selling an estimated $1.9M.
  • Knoll Capital Management's ten largest holdings make up 89% of its $201M portfolio in Q3 2021.
  • Knoll Capital Management opened 1 new position and closed 3 in Q3 2021.
  • Knoll Capital Management's portfolio value rose 4.7% quarter-over-quarter to $201M.

Based on Knoll Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.